Психиатрия как клиническая нейронаука: настоящее и будущее

Обложка

Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

Обзор литературы посвящён рассмотрению теоретических исследований в современной психиатрии как клинической представительницы нейронаук. Обсуждаются развитие персонализированного подхода в психиатрии, вопросы подготовки специалистов-психиатров в области нейробиологии, перспективы трансляции достижений психиатрической науки в клиническую практику, новые принципы систематизации психических расстройств.

Об авторах

Наталия Николаевна Петрова

Санкт-Петербургский государственный университет

Автор, ответственный за переписку.
Email: petrova_nn@mail.ru

профессор, заведующий кафедрой психиатрии и наркологии

Россия, 199034, г. Cанкт-Петербург, Университетская наб., 7/9

Мария Владимировна Дорофейкова

Институт эволюционной физиологии и биохимии им. И.М. Сеченова Российской академии наук

Email: mvdorofeykova@mail.ru

кандидат медицинских наук, научный сотрудник

Россия, 194223, г. Санкт-Петербург, пр. Тореза, 44

Список литературы

  1. Ryan T.A., Jin Y. Editorial overview: Molecular neuroscience. Curr. Opin. Neurobiol. 2019; 57: III–VI. doi: 10.1016/j.conb.2019.06.002.
  2. Lorusso L., Piccolino M., Motta S. et al. Neuroscience without borders: Preserving the history of neuroscience. Eur. J. Neurosci. 2018; 48: 2099–2109. doi: 10.1111/ejn.14101.
  3. Arbuckle M.R., Travis M.J., Ross D.A. Integrating a neuroscience perspective into clinical psychiatry today. JAMA Psychiatry. 2017; 74 (4): 313–314.
  4. Fung L.K., Akil M., Widge A. et al. Attitudes towards neuroscience education among psychiatry residents and fellows. Acad. Psychiatry. 2014; 38 (2): 127–134.
  5. Hassan T., Prasad B., Meek B.P., Modirrousta M. Attitudes of psychiatry residents in Canadian Universities toward neuroscience and its implication in psychiatric practice. Can. J. Psychiatry. 2020; 65 (3): 174–183. doi: 10.1177/0706743719881539.
  6. Ross D.A., Travis M.J., Arbuckle M.R. The future of psychiatry as clinical neuroscience: why not now? JAMA Psychiatry. 2015; 72 (5): 413–414.
  7. Benjamin S. Educating psychiatry residents in neuropsychiatry and neuroscience. Int. Rev. Psychiatry. 2013; 25 (3): 265–275. doi: 10.3109/09540261.2013.786689.
  8. Lüscher C. The future of clinical neuroscience: A view from the bench. Clin. Translat. Neurosci. 2018; 2 (2): 1–3. doi: 10.1177/2514183X18781315.
  9. Perna G., Nemeroff C.B. Personalized medicine in psychiatry: Back to the future. Personalized Med. Psychiatry. 2017; 1–2: 1–84.
  10. Fulford K.W.M., Bortolotti L., Broome M. Taking the long view: an emerging framework for translational psychiatric science. World Psychiatry. 2014; 13: 110–117. doi: 10.1002/wps.20139.
  11. Власова О.А. Философия психиатрии: четверть века дискуссий. Неврологич. вестн. 2020; LII (2): 12–19. [Vlasova O.A. Filosofiya psihiatrii: chetvert’ veka diskussij. Nevrologicheskij vestnik. 2020; LII (2): 12–19. (In Russ.)]
  12. Yahata N., Kasai K., Kawato M. Computational neuroscience approach to biomarkers and treatments for mental disorders. Psychiatry Clin. Neurosci. 2017; 71: 215–237.
  13. Young K.D., Zotev V., Phillips R. et al. Amygdala real-time functional magnetic resonance imaging neurofeedback for major depressive disorder: A review. Psychiatry Clin. Neurosci. 2018; 72: 466–481.
  14. Liu Y.N., Lu S.Y., Yao J. Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia. Psychiatry Clin. Neurosci. 2017; 71: 579–599.
  15. Kato T., Kanba S. Making psychiatry a clinical neuroscience-based medicine. Psychiatry Clin. Neurosci. 2019; 73: 1.
  16. Krueger R.F., Kotov R., Watson D. et al. Progress in achieving quantitative classification of psychopathology. World Psychiatry. 2018; 17 (3): 282–293.
  17. Kapur S., Phillips A.G., Insel T.R. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol. Psychiatry. 2012; 17: 1174–1179.
  18. Insel T., Cuthbert B., Garvey M. et al. Research Domain Criteria (RDoC): Toward a new classification framework for research on mental disorders. Am. J. Psychiatry. 2010; 167: 748–751.
  19. Cuthbert B.N. The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry. 2014; 13: 28–35.
  20. Krueger R.F., Markon K.E. A dimensional-spectrum model of psychopathology: progress and opportunities. Arch. Gen. Psychiatry. 2011; 68 (1): 10–11.
  21. Koudys J.W., Traynor J.M., Rodrigo A.H. et al. The NIMH Research Domain Criteria (RDoC) Initiative and its implications for research on personality disorder. Curr. Psychiatry Rep. 2019; 21: 37.
  22. Wium-Andersen I.K., Vinberg M., Kessing M.V., McIntyre R.S. Personalized medicine in psychiatry. Nordic J. Psychiatry. 2017; 71 (1): 12–19. doi: 10.1080/08039488.2016.1216163.
  23. Greenwood T.A., Shutes-David A., Tsuang D.W. Endophenotypes in schizophrenia: Digging deeper to identify genetic mechanisms. J. Psychiatr. Brain Sci. 2019; 4 (2): e190005. doi: 10.20900/jpbs.20190005.
  24. Holmes A.J., Patrick L.M. The myth of optimality in clinical neuroscience. Trends Cogn. Sci. 2018; 22 (3): 241–257.
  25. Thompson P.M., Jahanshad N., Ching C.R.K. et al. ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries. Transl. Psychiatry. 2020; 10 (1): 100. doi: 10.1038/s41398-020-0705-1.
  26. Baker J.T., Holmes A.J., Masters G.A. et al. Disruption of cortical association networks in schizophrenia and psychotic bipolar disorder. JAMA Psychiatry. 2014; 71 (2): 109–118. doi: 10.1001/jamapsychiatry.2013.3469.
  27. Datta D., Arnsten A.F.T. Unique molecular regulation of higher-order prefrontal cortical circuits: Insights into the neurobiology of schizophrenia. ACS Chem. Neurosci. 2018; 9 (9): 2127–2145. doi: 10.1021/acschemneuro.7b00505.
  28. Sheffield J.M., Kandala S., Tamminga C.A. et al. Transdiagnostic associations between functional brain network integrity and cognition. JAMA Psychiatry. 2017; 74 (6): 605–613. doi: 10.1001/jamapsychiatry.2017.0669.
  29. Kimoto S., Makinodan M., Kishimoto T. Neurobiology and treatment of social cognition in schizophrenia: Bridging the bed-bench gap. Neurobiol. Dis. 2019; 131: 104315. doi: 10.1016/j.nbd.2018.10.022.
  30. Yang C., Qi A., Yu H. et al. Different levels of facial expression recognition in patients with first-episode schizophrenia: A functional MRI study. Gen. Psychiatr. 2018; 31 (2): e000014.
  31. Kircher T., Bröhl H., Meier F., Engelen J. Formal thought disorders: from phenomenology to neurobiology. Lancet Psychiatry. 2018; 5 (6): 515–526. doi: 10.1016/S2215-0366(18)30059-2.
  32. Lo M.-C., Widge A.S. Closed-loop neuromodulation systems: Next-generation treatments for psychiatric illness. Int. Rev. Psychiatry. 2017; 29 (2): 191–204.
  33. Hsin H., Fromer M., Peterson B. et al. Transforming psychiatry into data-driven medicine with digital measurement tools. NPJ Digit. Med. 2018; 1: 37.
  34. Al Dahhan N.Z., De Felice F.G., Munoz D.P. Potentials and Pitfalls of Cross-Translational Models of Cognitive Impairment. Front. Behav. Neurosci. 2019; 13: 48. doi: 10.3389/fnbeh.2019.00048.

© Петрова Н.Н., Дорофейкова М.В., 2021

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах